RxDoctor Payments Data

Estevan del Castillo, MD

Family Medicine · Punta Gorda, FLNPI 1902268725

Payments from drug & device makers

$9,318in general payments, 2019–2025

Across 478 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • Amgen$991
  • GSK$756
  • Lilly USA, LLC$706
  • Pfizer$386
  • plus $3K from 46 others

What the payments were for

  • Food & beverage$9,314100%
  • Education$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,318 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$306,410
Medicare patients
468
Services billed
14,694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide139$241,482
EliquisApixaban147$188,425
MounjaroTirzepatide69$100,466
JardianceEmpagliflozin61$90,678
OtezlaApremilast14$67,539
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$67,294
FarxigaDapagliflozin Propanediol23$35,830
TrulicityDulaglutide28$35,763
Tresiba Flextouch U-100Insulin Degludec24$31,837
XareltoRivaroxaban19$30,577
RybelsusSemaglutide12$26,121
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$20,582
Breo ElliptaFluticasone/Vilanterol21$16,824
Repatha SureclickEvolocumab11$16,401
JanuviaSitagliptin Phosphate11$15,249

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$2,076$267,604151 claims
PfizerEliquis$386$188,425147 claims
Lilly USA, LLCMounjaro, Trulicity$706$136,22997 claims
Boehringer IngelheimJardiance$26$90,67861 claims
GSKTrelegy Ellipta, Breo Ellipta$756$84,11769 claims
AmgenOtezla$991$67,53914 claims
AstraZenecaFarxiga, Breztri Aerosphere$79$56,41336 claims
Johnson & JohnsonXarelto$18$30,57719 claims
AbbVieLinzess, Synthroid$1,269$15,26959 claims
MerckJanuvia$116$15,24911 claims
Astellas Pharma US IncMyrbetriq$44$13,28012 claims
Currax Pharmaceuticals LLCContrave$63$7,68211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Punta Gorda

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →